North America Microarray Market Size was valued at USD 0.29 Billion in 2023. The North America Microarray industry is projected to grow from USD 0.31 Billion in 2024 to USD 0.55 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.36% during the forecast period (2024 - 2032). North America the market for Microarray is increasing rapidly. A microarray is a multiplex lab-on-a-chip. It is a 2D array on a solid substrate, usually a glass slide or silicon thin-film cell, that assays large amounts of biological material using high-throughput screening miniaturized, multiplexed and parallel processing and detection methods. Globally the microarray market is dominated by DNA microarrays. The protein microarray is currently the fastest growing market. The use of peptide and carbohydrate microarrays is expanding. Tissue and cell microarrays are in their infancy stage and are developing slowly because of many complications in the process development.
The AxiomTM PangenomiX Array*, the most ethnically diverse and largest array to date, was introduced by Thermo Fisher Scientific in January 2024. This array provides optimal genetic coverage for pharmacogenomic research and population-scale disease investigations. The majority of the current large-scale genomic datasets, which are utilized for downstream meta-analysis to construct and comprehend disease risk prediction models, are derived from European and Caucasian cohorts. The urgent need for ethnically diverse data sets to generate genetic insights in other populations, such as African, Asian, and increasing mixed populations, is exacerbated by the increasingly diverse and blended global community. Additionally, the healthcare sector is transitioning to a proactive care model, which underscores the significance of conducting research on the influence of genetics on drug response and disease risk. At present, the PangenomiX Array is the sole research solution that integrates four assays into a single test: SNP genotyping, whole genome copy number variant detection, fixed copy number discovery, blood, and HLA typing. The high-throughput array is intended to facilitate the advancement of ancestry and wellness testing, population-scale disease research programs, drug efficacy testing, and drug development research, as well as disease risk and detection research.
In September 2023, Thermo Fisher Scientific introduced a new chromosomal microarray that is intended to enhance the productivity, efficiency, and profitability of cytogenetic research labs. This microarray boasts an industry-leading two-day turnaround time. The Applied Biosystems™ CytoScan™ HD Accel array analyzes the entire human genome and offers enhanced coverage in over 5,000 critical genome regions, providing valuable insights on chromosomal variants for a diverse array of prenatal, postnatal, and oncology research applications. Labs are under pressure to enhance efficacy in order to accommodate the increasing volumes, as there is a persistent shortage of trained laboratory professionals and a growing demand for laboratory services. The CytoScan HD Accel array has the potential to enhance the productivity of assays by up to 100% in laboratories that have an existing apparatus base. The new array also reduces the time required for sample handling and preparation, and it necessitates up to 50% less input sample—as little as 100 ng input DNA—than other commercially available chromosomal microarrays.
Key Finding
North America Microarray market has been segmented on the basis of types which comprises of protein microarray, tissue microarray, and cellular microarray.
On the basis of product, North America Tissue microarray market is segmented into paraffin tissue sections (FFPE), frozen tissue sections, and others.
On the basis of applications, tissue microarray market is segmented into immunohistochemistry, in-situ hybridization, and others.
Regional Analysis
In North America, U.S. is the largest market for Tissue Microarray. Canada is the second-largest market and is expected to be fastest growing market for Tissue Microarray in North America.
Key Players for North America Microarray Market
Some of the key players in this North America Microarray Market are:
Study objectives of Microarray Market:
Intended Audience
The report for North America Microarray Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions
| Report Attribute/Metric | Details |
| Market Size | 0.55 billion |
| CAGR | 7.36% |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2021 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | type, application |
| Geographies Covered | U.S. and Canada |
| Key Vendors | ABCAM, ASTERAND BIOSCIENCE, IHC WORLD LLC, NOVUS BIOLOGICALS LLC (ACQUIRED BY BIO-TECHNE), ORIGENE TECHNOLOGIES INC, PANTOMICS, INC, PROTEIN BIOTECHNOLOGIES INC, US BIOMAX, INC., US BIOUPTON INT, VITROVIVO BIOTECH |
| Key Market Opportunities | Joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments |
| Key Market Drivers | technological advancement, macro economical and governing factors |
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
